AUSCANN GROUP S Share · AU000000AC89 · A2DLBP (XASX) Australia · Healthcare — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of AUSCANN GROUP S

No Price

Company Profile for AUSCANN GROUP S Share

AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.

Company Data

Name AUSCANN GROUP S

Company AusCann Group Holdings Ltd

Website https://auscann.com.au

Primary Exchange

ASX

WKN A2DLBP

ISIN AU000000AC89

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Christopher Mews B. Bus,

Country Australia

Currency EUR

Employees 0,0 T

Address 35 Havelock Street, 6005 West Perth

IPO Date 2017-02-10

Key Ratios

Valuation

P/E Ratio -1,63x

P/B Ratio 1,03x

P/S Ratio 15,92x

P/FCF Ratio -4,82x

Margins

Gross Margin 95,84 %

Operating Margin -124,75 %

Net Margin -977,06 %

As of 27.06.2026

Ticker Symbols

Name	Symbol
Over The Counter	ACNNF